Literature DB >> 12503696

Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults.

P Lange1, J Parner, P Schnohr, G Jensen.   

Abstract

The natural history of lung function in diabetes is unknown due to the lack of longitudinal observations. The decline of forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) was studied over 15 yrs in the 17,506 adult participants of The Copenhagen City Heart Study, which included 266 individuals with diabetes. Multiple linear regression and a mixed-effects model were used, taking into account correlation between repeated measurements and adjusting for relevant confounders. In both sexes, FEV1 and FVC were consistently lower in diabetic individuals, compared with healthy individuals, with an average reduction of approximately 8% of the predicted value. Longitudinal analyses showed that the decline of FEV1 and FVC in diabetic individuals was similar to that observed in nondiabetic subjects. It was concluded that although diabetic subjects have, on average, a lower forced expiratory volume in one second and forced vital capacity than individuals without diabetes, this deficit seems not to be progressive in the long term. These observations may be of importance with regard to diabetes treatment with inhaled pulmonary insulin, which is likely to become available within a few years.

Entities:  

Mesh:

Year:  2002        PMID: 12503696     DOI: 10.1183/09031936.02.00050502

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  24 in total

1.  Vital capacity and selected metabolic diseases in middle-aged Japanese men.

Authors:  H Sakuta; Takashi Suzuki; Hiroko Yyasuda; Teizo Ito
Journal:  Can Respir J       Date:  2006-03       Impact factor: 2.409

2.  Alveolar Gas Exchange and Pulmonary Functions in Patients with Type II Diabetes Mellitus.

Authors:  Anandhalakshmi S; Manikandan S; Ganeshkumar P; Ramachandran C
Journal:  J Clin Diagn Res       Date:  2013-08-28

Review 3.  The diabetic lung--a new target organ?

Authors:  Dario Pitocco; Leonello Fuso; Emanuele G Conte; Francesco Zaccardi; Carola Condoluci; Giuseppe Scavone; Raffaele A Incalzi; Giovanni Ghirlanda
Journal:  Rev Diabet Stud       Date:  2012-05-10

4.  Glycemic control influences lung membrane diffusion and oxygen saturation in exercise-trained subjects with type 1 diabetes: alveolar-capillary membrane conductance in type 1 diabetes.

Authors:  Courtney M Wheatley; James C Baldi; Nicholas A Cassuto; William T Foxx-Lupo; Eric M Snyder
Journal:  Eur J Appl Physiol       Date:  2010-10-10       Impact factor: 3.078

5.  Associations of measures of lung function with insulin resistance and Type 2 diabetes: findings from the British Women's Heart and Health Study.

Authors:  D A Lawlor; S Ebrahim; G Davey Smith
Journal:  Diabetologia       Date:  2003-12-24       Impact factor: 10.122

6.  Pulmonary function tests in type 2 diabetics and non-diabetic people -a comparative study.

Authors: 
Journal:  J Clin Diagn Res       Date:  2013-08-01

7.  Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Hsin-Chieh Yeh; Naresh M Punjabi; Nae-Yuh Wang; James S Pankow; Bruce B Duncan; Christopher E Cox; Elizabeth Selvin; Frederick L Brancati
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

8.  Association between glycemic state and pulmonary function and effect of walking as a protective factor in subjects with diabetes mellitus.

Authors:  Ji Min Kim; Min Kyeong Kim; Kyong Hye Joung; Ju Hee Lee; Hyun Jin Kim; Bon Jeong Ku
Journal:  Ann Transl Med       Date:  2019-10

9.  Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.

Authors:  Samantha F Ehrlich; Charles P Quesenberry; Stephen K Van Den Eeden; Jun Shan; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

Review 10.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.